Minocycline Reduces the Lipopolysaccharide-Induced Inflammatory Reaction, Peroxynitrite-Mediated Nitration of Proteins, Disruption of the Blood–Brain Barrier, and Damage in the Nigral Dopaminergic System

The Rat Brain in Stereotaxic Coordinates

Paxinos, G., & Watson, C. (1983) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 28,585 · see citing works

Microglia: a sensor for pathological events in the CNS

Kreutzberg, G. W. (1996) · Trends in Neurosciences · doi:10.1016/0166-2236(96)10049-7 · Cited by 4,396 · see citing works

The new stereological tools: Disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis

Gundersen, H. J. G., Bagger, P. V., Bendtsen, T. F., Evans, S. M., Korbo, L., Marcussen, N., Møller, A., Nielsen, K. N., Nyengaard, J. R., Pakkenberg, B., et al. (1988) · Apmis · doi:10.1111/j.1699-0463.1988.tb00954.x · Cited by 2,480 · see citing works

Oxidative stress in Parkinson's disease

Jenner, P. (2003) · Annals of Neurology · doi:10.1002/ana.10483 · Cited by 2,053 · see citing works

Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain

Lawson, L. J., Perry, V. H., Dri, P., & Gordon, S. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90229-w · Cited by 2,045 · see citing works

New roles for astrocytes: redefining the functional architecture of the brain.

Nedergaard, M., Ransom, B., & Goldman, S. A. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.008 · Cited by 1,334 · see citing works

The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases

MCGEER, P., & MCGEER, E. (1995) · Brain Research Reviews · doi:10.1016/0165-0173(95)00011-9 · Cited by 1,287 · see citing works

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine

Nicklas, W. J., Vyas, I. L., & Heikkila, R. E. (1985) · Life Sciences · doi:10.1016/0024-3205(85)90146-8 · Cited by 1,266 · see citing works

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works

Oxidative Pathways for Catecholamines in the Genesis of Neuromelanin and Cytotoxic Quinones

GRAHAM, D. G. (1978) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13535-9 · Cited by 1,126 · cited 1× · see citing works

Role of Microglia in Inflammation-Mediated Neurodegenerative Diseases: Mechanisms and Strategies for Therapeutic Intervention

Liu, B., & Hong, J.-S. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.035048 · Cited by 1,095 · see citing works

Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice

Zhu, S., Stavrovskaya, I. G., Drozda, M., Kim, B. Y. S., Ona, V. O., Li, M., Sarang, S. S., Liu, A. S., Hartley, D. M., Wu, D. C., et al. (2002) · Nature · doi:10.1038/417074a · Cited by 1,071 · see citing works

Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

Chen, M., Ona, V. O., Li, M., Ferrante, R. J., Fink, K., Zhu, S., Bian, J., Guo, L., Farrell, L. A., Hersch, S. M., et al. (2000) · Nature Medicine · doi:10.1038/77528 · Cited by 1,056 · see citing works

A tetracycline derivative, minocycline, reduces inflammation and protects against focal cerebral ischemia with a wide therapeutic window

Yrjänheikki, J., Kauppinen, T. M., Keinänen, R., Goldsteins, G., Chan, P. H., & Koıstınaho, J. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.23.13496 · Cited by 1,040 · see citing works

Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia

Yrjänheikki, J., Keinänen, R., Pellikka, M., Hökfelt, T., & Koistinaho, J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.26.15769 · Cited by 1,006 · see citing works

Oxidative stress and the pathogenesis of Parkinson's disease

Jenner, P., & Olanow, C. W. (1996) · Neurology · doi:10.1212/wnl.47.6_suppl_3.161s · Cited by 971 · see citing works

Minocycline, a tetracycline derivative, is neuroprotective against excitotoxicity by inhibiting activation and proliferation of microglia

Tikka, T., Fiebich, B. L., Goldsteins, G., Keinänen, R., & Koistinaho, J. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-08-02580.2001 · Cited by 958 · see citing works

Regional Difference in Susceptibility to Lipopolysaccharide-Induced Neurotoxicity in the Rat Brain: Role of Microglia

Kim, W., Mohney, R. P., Wilson, B. C., Jeohn, G., Liu, B., & Hong, J. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-16-06309.2000 · Cited by 881 · see citing works

Pathophysiology of the basal ganglia in Parkinson's disease

Obeso, J. A., Rodríguez‐Oroz, M., Rodrı́guez, M., Lanciego, J. L., Artieda, J., Gonzalo, N., & Olanow, C. W. (2000) · Trends in Neurosciences · doi:10.1016/s1471-1931(00)00028-8 · Cited by 841 · see citing works

Interleukin-1β and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients

Blum-Degena, D., Müller, T., Kuhn, W., Gerlach, M., Przuntek, H., & Riederer, P. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)12192-7 · Cited by 801 · see citing works

Minocycline Prevents Nigrostriatal Dopaminergic Neurodegeneration in the MPTP Model of Parkinson’s Disease

Du, Y., Ma, Z., Lin, S., Dodel, R. C., Gao, F., Bales, K. R., Triarhou, L. C., Chernet, E., Perry, K. W., Nelson, D. L. G., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251341998 · Cited by 789 · see citing works

Microglial activation‐mediated delayed and progressive degeneration of rat nigral dopaminergic neurons: relevance to Parkinson's disease

Gao, H., Jiang, J., Wilson, B. C., Zhang, W., Hong, J., & Liu, B. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00928.x · Cited by 690 · see citing works

Tetracyclines Inhibit Connective Tissue Breakdown by Multiple Non-Antimicrobial Mechanisms

Golub, L. M., Lee, H. M., RYAN, M. E., Giannobile, W. V., Payne, J. B., & Sorsa, T. A. (1998) · Advances in Dental Research · doi:10.1177/08959374980120010501 · Cited by 689 · see citing works

Mitochondrial dysfunction in neurodegenerative diseases

Beal, M. F. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00114-5 · Cited by 608 · see citing works

Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson's disease

Boka, G., Anglade, P., Wallach, D., Javoy-Agid, F., Agid, Y., & Hirsch, É. C. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90684-x · Cited by 591 · see citing works

Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

Chen, D., Endres, R. L., Erickson, C. A., Weis, K. F., McGregor, M. W., Kawaoka, Y., & Payne, L. G. (2000) · Nature Medicine · doi:10.1038/80538 · Cited by 547 · see citing works

Interleukin (IL)-1β, IL-2, IL-4, IL-6 and transforming growth factor-α levels are elevated in ventricular cerebrospinal fluid in juvenile parkinsonism and Parkinson's disease

Mogi, M., Harada, M., Narabayashi, H., Inagaki, H., Minami, M., & Nagatsu, T. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12706-3 · Cited by 545 · see citing works

Mitochondria, Oxidative Damage, and Inflammation in Parkinson's Disease

Beal, M. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07470.x · Cited by 523 · see citing works

A novel mechanism of action of tetracyclines: Effects on nitric oxide synthases

Amin, A. R., Attur, M. G., Thakker, G. D., Patel, P. D., Vyas, P., Patel, R. N., Patel, I. R., & Abramson, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.24.14014 · Cited by 474 · see citing works

The Role of Glial Reaction and Inflammation in Parkinson's Disease

Hirsch, É. C., Breidert, T., Rousselet, E., Hunot, S., Hartmann, A., & Michel, P. P. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb07478.x · Cited by 449 · see citing works

Neurodegenerative disorders: the role of peroxynitrite

Torreilles, F., Salman-Tabcheh, S., Guérin, M.-C., & Torreilles, J. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00014-4 · Cited by 430 · see citing works

Genetic and environmental factors in the cause of Parkinson's disease

Warner, T. T., & Schapira, A. H. V. (2003) · Annals of Neurology · doi:10.1002/ana.10487 · Cited by 399 · see citing works

Lipopolysaccharide Intranigral Injection Induces Inflammatory Reaction and Damage in Nigrostriatal Dopaminergic System

Castaño, A., Herrera, A. J., Cano, J., & Machado, A. (1998) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1998.70041584.x · Cited by 393 · see citing works

The Single Intranigral Injection of LPS as a New Model for Studying the Selective Effects of Inflammatory Reactions on Dopaminergic System

Herrera, A. J., Castaño, A., Venero, J. L., Cano, J., & Machado, A. (2000) · Neurobiology of Disease · doi:10.1006/nbdi.2000.0289 · Cited by 392 · see citing works

An evaluation of the role of mitochondria in neurodegenerative diseases: mitochondrial mutations and oxidative pathology, protective nuclear responses, and cell death in neurodegeneration

Cassarino, D. S., & Bennett, J. P. (1999) · Brain Research Reviews · doi:10.1016/s0165-0173(98)00046-0 · Cited by 379 · see citing works

Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction

Sanchez-Mejia, R., Ona, V., Li, M.-W., & Friedlander, R. (2001) · Neurosurgery · doi:10.1097/00006123-200106000-00051 · Cited by 373 · see citing works

FcεRII/CD23 Is Expressed in Parkinson’s Disease and Induces,In Vitro,Production of Nitric Oxide and Tumor Necrosis Factor-α in Glial Cells

Hunot, S., Dugas, N., Faucheux, B. A., Hartmann, A., Tardieu, M., Debré, P., Agid, Y., Dugas, B., & Hirsch, É. C. (1999) · Journal of Neuroscience · doi:10.1523/jneurosci.19-09-03440.1999 · Cited by 365 · see citing works

Enzymatic Oxidation of Dopamine: The Role of Prostaglandin H Synthase

Hastings, T. G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64020919.x · Cited by 359 · see citing works

Minocycline inhibits microglial activation and protects nigral cells after 6-hydroxydopamine injection into mouse striatum

He, Y., Appel, S. H., & Le, W. (2001) · Brain Research · doi:10.1016/s0006-8993(01)02681-6 · Cited by 350 · see citing works

Naloxone Protects Rat Dopaminergic Neurons against Inflammatory Damage through Inhibition of Microglia Activation and Superoxide Generation

Liu, B., Du, L., & Hong, J.-S. (2000) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)39275-4 · Cited by 347 · see citing works

New roles for astrocytes (stars at last)

Ransom, B. R., Behar, T. N., & Nedergaard, M. (2003) · Trends in Neurosciences · doi:10.1016/j.tins.2003.08.006 · Cited by 335 · see citing works

Minocycline markedly protects the neonatal brain against hypoxic‐ischemic injury

Arvin, K. L., Han, B., Du, Y.-S., Lin, S.-Z., Paul, S. M., & Holtzman, D. (2002) · Annals of Neurology · doi:10.1002/ana.10242 · Cited by 323 · see citing works

An inflammatory review of Parkinson's disease

Orr, C. F., Rowe, D. B., & Halliday, G. M. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00127-2 · Cited by 309 · see citing works

Inhibition of autoimmune encephalomyelitis by a tetracycline

Popovic, N., Schubart, A., Goetz, B. D., Zhang, S., Linington, C., & Duncan, I. D. (2002) · Annals of Neurology · doi:10.1002/ana.10092 · Cited by 295 · see citing works

Ischaemic brain oedema

Ayata, C., & Ropper, A. H. (2002) · Journal of Clinical Neuroscience · doi:10.1054/jocn.2001.1031 · Cited by 276 · see citing works

Serine proteases and brain damage – is there a link?

Gingrich, M. B., & Traynelis, S. F. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(00)01617-9 · Cited by 274 · see citing works

Involvement of inducible nitric oxide synthase in inflammation-induced dopaminergic neurodegeneration.

Iravani, M. M., Kashefi, K., Mander, P., Rose, S., & Jenner, P. (2002) · Neuroscience · doi:10.1016/s0306-4522(01)00562-0 · Cited by 247 · see citing works

The degenerative effect of a single intranigral injection of LPS on the dopaminergic system is prevented by dexamethasone, and not mimicked by rh‐TNF‐α, IL‐1β and IFN‐γ

Castaño, A., Herrera, A. J., Cano, J., & Machado, A. M. (2002) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2002.00799.x · Cited by 239 · see citing works

Microglial Response to Brain Injury: A Brief Synopsis

Streit, W. J. (2000) · Toxicologic Pathology · doi:10.1177/019262330002800104 · Cited by 230 · see citing works

Dextromethorphan Protects Dopaminergic Neurons against Inflammation-Mediated Degeneration through Inhibition of Microglial Activation

Liu, Y., Qin, L., Li, G., Zhang, W., An, L., Liu, B., & Hong, J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.102.043166 · Cited by 205 · see citing works

Up-regulation of inducible nitric oxide synthase in the substantia nigra by lipopolysaccharide causes microglial activation and neurodegeneration.

Arimoto, T., & Bing, G. (2003) · Neurobiology of Disease · doi:10.1016/s0969-9961(02)00017-7 · Cited by 202 · see citing works

Lipopolysaccharide (LPS)-induced dopamine cell loss in culture: roles of tumor necrosis factor-α, interleukin-1β, and nitric oxide

Gayle, D. A., Ling, Z., Tong, C. W., Landers, T. M., Lipton, J. W., & Carvey, P. M. (2002) · Developmental Brain Research · doi:10.1016/s0165-3806(01)00315-7 · Cited by 201 · see citing works

Biochemistry and cell biology of bacterial endotoxins

Holst, O., Ulmer, A. J., Brade, H., Flad, H., & Rietschel, E. (1996) · FEMS Immunology & Medical Microbiology · doi:10.1111/j.1574-695x.1996.tb00126.x · Cited by 196 · see citing works

Astrocytic demise precedes delayed neuronal death in focal ischemic rat brain

Liu, D., Smith, C. L., Barone, F. C., Ellison, J. A., Lysko, P. G., Li, K., & Simpson, I. A. (1999) · Molecular Brain Research · doi:10.1016/s0169-328x(99)00063-7 · Cited by 179 · see citing works

Minocycline Reduces Traumatic Brain Injury-mediated Caspase-1 Activation, Tissue Damage, and Neurological Dysfunction

Mejia, R. O. S., Ona, V. O., Li, M., et al. (2001) · Neurosurgery · doi:10.1227/00006123-200106000-00051 · Cited by 171 · see citing works

Systemic Infusion of Naloxone Reduces Degeneration of Rat Substantia Nigral Dopaminergic Neurons Induced by Intranigral Injection of Lipopolysaccharide

Liu, B., Jiang, J., Wilson, B. C., Du, L., Yang, S., Wang, J., Wu, G.-C., Cao, X.-D., & Hong, J. (2000) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38877-9 · Cited by 167 · see citing works

Astrogliosis in the Neonatal and Adult Murine Brain Post-Trauma: Elevation of Inflammatory Cytokines and the Lack of Requirement for Endogenous Interferon-γ

Rostworowski, M., Balasingam, V., Chabot, S., Owens, T., & Yong, V. W. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-10-03664.1997 · Cited by 154 · see citing works

CD14 and other recognition molecules for lipopolysaccharide: A review

Kielian, T. L., & Blecha, F. (1995) · Immunopharmacology · doi:10.1016/0162-3109(95)00003-c · Cited by 152 · see citing works

Early loss of astrocytes after experimental traumatic brain injury

Zhao, X., Ahram, A., Berman, R. F., Muizelaar, J. P., & Lyeth, B. G. (2003) · Glia · doi:10.1002/glia.10283 · Cited by 150 · see citing works

In Vivo Autoxidation of Dopamine in Guinea Pig Striatum Increases with Age

Fornstedt, B., Pileblad, E., & Carlsson, A. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb04183.x · Cited by 143 · see citing works

Further studies on the generation of hydrogen peroxide by 6-hydroxydopamine. Potentiation by ascorbic acid.

Heikkila, R. E., & Cohen, G. (1972) · PubMed · Cited by 143 · see citing works

Emerging molecular mechanisms of brain tumour oedema

Papadopoulos, S. S. M. C. (2001) · British Journal of Neurosurgery · doi:10.1080/02688690120036775 · Cited by 140 · see citing works

Immune processes in the pathogenesis of Parkinson's disease - a potential role for microglia and nitric oxide.

Członkowska, A., Kurkowska‐Jastrzębska, I., Członkowski, A., Peter, D., & Stefano, G. B. (2002) · PubMed · Cited by 123 · see citing works

Free radicals in Parkinson's disease

Koutsilieri, E., Scheller, C., Grünblatt, E., Keinosuke, N. A. R. A., Li, J., & Riederer, P. F. (2002) · Journal of Neurology · doi:10.1007/s00415-002-1201-7 · Cited by 117 · see citing works

Modulation of Bone Resorption by Tetracyclinesa

Rifkin, B. R., Vernillo, A., Golub, L. M., & RAMAMURTHY, N. S. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb24733.x · Cited by 89 · see citing works

Naloxone prevents microglia-induced degeneration of dopaminergic substantia nigra neurons in adult rats

Lu, X., Bing, G., & Hagg, T. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00033-6 · Cited by 89 · see citing works

Induction of Nitric Oxide Synthase and Microglial Responses Precede Selective Cell Death Induced by Chronic Impairment of Oxidative Metabolism

Calingasan, N. Y., Park, L. C. H., Calo, L. L., Trifiletti, R. R., Gandy, S., & Gibson, G. E. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65602-7 · Cited by 85 · see citing works

Impaired cytokine production by peripheral blood mononuclear cells and monocytes/macrophages in Parkinson's disease

Hasegawa, Y., Inagaki, T., Sawada, M., & Suzumura, A. (2000) · Acta Neurologica Scandinavica · doi:10.1034/j.1600-0404.2000.101003159.x · Cited by 78 · see citing works

Thrombin induces in vivo degeneration of nigral dopaminergic neurones along with the activation of microglia

Carreño‐Müller, E., Herrera, A. J., de Pablos, R. M., Tomás‐Camardiel, M., Venero, J. L., Cano, J., & Machado, A. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01634.x · Cited by 70 · see citing works

Femtomolar Concentrations of Dynorphins Protect Rat Mesencephalic Dopaminergic Neurons against Inflammatory Damage

Liu, B., Qin, L., Yang, S., Wilson, B. C., Liu, Y., & Hong, J. (2001) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)29483-0 · Cited by 65 · see citing works

p38 MAP Kinase Is Involved in Lipopolysaccharide‐Induced Dopaminergic Neuronal Cell Death in Rat Mesencephalic Neuron‐Glia Cultures

Jeohn, G., Cooper, C. L., Wilson, B. C., Chang, R. C., Jang, K., Kim, H.-C., Liu, B., & Hong, J. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04078.x · Cited by 60 · see citing works

Delayed minocycline but not delayed mild hypothermia protects against embolic stroke

Wang, C. X., Yang, T., Noor, R., & Shuaib, A. M. (2002) · BMC Neurology · doi:10.1186/1471-2377-2-2 · Cited by 59 · see citing works

Spatiotemporal induction patterns of cytokine and related immune signal molecule mRNAs in response to intrastriatal injection of lipopolysaccharide

Stern, E. L., Quan, N., Proescholdt, M. G., & Herkenham, M. A. (2000) · Journal of Neuroimmunology · doi:10.1016/s0165-5728(00)00318-0 · Cited by 57 · see citing works

A one-step immunohistochemical method for detection of blood—brain barrier disturbances for immunoglobulins in lesioned rat brain with special reference to false-positive labelling in immunohistochemistry

Schmidt‐Kastner, R., Meller, D., Bellander, B., Strömberg, I., Olson, L., & Ingvar, M. (1993) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(93)90147-j · Cited by 54 · see citing works

Inflammation in Parkinson's disease

Wüllner, U., & Klockgether, T. (2003) · Journal of Neurology · doi:10.1007/s00415-003-1107-x · Cited by 44 · see citing works

Effects of Dexamethasone on IL-1β, IL-6, and TNF-α Production by Mononuclear Cells of Newborns and Adults

Bessler, H., Mendel, C., Straussberg, R., Gurary, N., Aloni, D., & Sirota, L. (1999) · Neonatology · doi:10.1159/000014099 · Cited by 43 · see citing works

Nitric oxide modulates blood-brain barrier permeability during infections with an inactivated bacterium

Shukla, A., Dikshit, M., & Srimal, R. C. (1995) · Neuroreport · doi:10.1097/00001756-199508000-00010 · Cited by 42 · see citing works

Reduced expressions of inducible nitric oxide synthase and cyclooxygenase-2 in vascular smooth muscle cells of stroke-prone spontaneously hypertensive rats

Hirafuji, M., Tsunoda, M., Machida, T., Hamaue, N., Endo, T., Miyamoto, A., & Minami, M. (2002) · Life Sciences · doi:10.1016/s0024-3205(01)01464-3 · Cited by 30 · see citing works

Production of digoxigenin-labelled RNA probes and the detection of cytokine mRNA in rat spleen and brain by in situ hybridization

Meltzer, J. C., Sanders, V., Grimm, P. C., Stern, E. L., RIVIER, C. L., Lee, S., Rennie, S. L., Gietz, R. D., Hole, A. K., Watson, P. H., et al. (1998) · Brain Research Protocols · doi:10.1016/s1385-299x(98)00010-5 · Cited by 29 · see citing works

Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease

Turner, M. D., Nedjai, B., Hurst, T. P., & Pennington, D. J. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2014.05.014 · Cited by 2,186 · see citing works

Neuroinflammation in Parkinson's disease: Its role in neuronal death and implications for therapeutic intervention

Tansey, M. G., & Goldberg, M. S. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.11.004 · Cited by 1,045 · see citing works

Minocycline: Far beyond an Antibiotic

Garrido‐Mesa, N., Zarzuelo, A., & Gálvez, J. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12139 · Cited by 935 · see citing works

Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Köhler, O., Benros, M. E., Nordentoft, M., Farkouh, M. E., Iyengar, R. L., Mors, O., & Krogh, J. (2014) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2014.1611 · Cited by 941 · see citing works

Neuroinflammation in Parkinson's disease and its potential as therapeutic target

Wang, Q., Liu, Y., & Zhou, J. (2015) · Translational Neurodegeneration · doi:10.1186/s40035-015-0042-0 · Cited by 884 · see citing works

TNF signaling inhibition in the CNS: implications for normal brain function and neurodegenerative disease

McCoy, M. K., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-45 · Cited by 843 · see citing works

Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response

Bachiller, S., Jiménez-Ferrer, I., Paulus, A., Yang, Y., Swanberg, M., Deierborg, T., & Boza‐Serrano, A. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00488 · Cited by 706 · see citing works

Minocycline attenuates lipopolysaccharide (LPS)-induced neuroinflammation, sickness behavior, and anhedonia

Henry, C. J., Huang, Y., Wynne, A., Hanke, M., Himler, J., Bailey, M. T., Sheridan, J. F., & Godbout, J. P. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-15 · Cited by 678 · see citing works

Inflammation as a causative factor in the aetiology of Parkinson's disease

Whitton, P. S. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707167 · Cited by 625 · see citing works

Neuroinflammatory mechanisms in Parkinson's disease: Potential environmental triggers, pathways, and targets for early therapeutic intervention

Tansey, M. G., McCoy, M. K., & Frank-Cannon, T. C. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2007.07.004 · Cited by 580 · see citing works

Microglia in Neuroinflammation and Neurodegeneration: From Understanding to Therapy

Muzio, L., Viotti, A., & Martino, G. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.742065 · Cited by 581 · see citing works

Mitochondrial Dysfunction and Biogenesis in Neurodegenerative diseases: Pathogenesis and Treatment

Golpich, M., Amini, E., Mohamed, Z., Raymond, A. A., Ibrahim, N. M., & Ahmadiani, A. (2016) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12655 · Cited by 540 · see citing works

The Promise of Minocycline in Neurology

Yong, V. W., Wells, J., Giuliani, F., Casha, S., Power, C., & Metz, L. M. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00937-8 · Cited by 518 · see citing works

Inflammation in Depression and the Potential for Anti-Inflammatory Treatment

Kohler, O., Krogh, J., Mors, O., & Eriksen Benros, M. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666151208113700 · Cited by 516 · see citing works

Microglial activation and TNFα production mediate altered CNS excitability following peripheral inflammation

Riazi, K., Galic, M. A., Kuzmiski, J. B., Ho, W., Sharkey, K. A., & Pittman, Q. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0806682105 · Cited by 400 · see citing works

Neurodegeneration and Inflammation—An Interesting Interplay in Parkinson’s Disease

Marogianni, C., Sokratous, M., Dardiotis, E., Hadjigeorgiou, G. M., Bogdanos, D. P., & Xiromerisiou, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228421 · Cited by 369 · see citing works

Microglia Potentiate Damage to Blood–Brain Barrier Constituents: Improvement by Minocycline In Vivo and In Vitro

Yenari, M. A., Xu, L., Tang, X. N., Qiao, Y., & Giffard, R. G. (2006) · Stroke · doi:10.1161/01.str.0000206281.77178.ac · Cited by 359 · see citing works

Contributions of central and systemic inflammation to the pathophysiology of Parkinson's disease

Collins, L. M., Toulouse, A., Connor, T. J., & Nolan, Y. M. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.01.028 · Cited by 275 · see citing works

The influence of microglia on the pathogenesis of Parkinson's disease

Long-Smith, C. M., Sullivan, A. M., & Nolan, Y. M. (2009) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2009.08.001 · Cited by 296 · see citing works

Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases

Spielman, L. J., Gibson, D. L., & Klegeris, A. (2018) · Neurochemistry International · doi:10.1016/j.neuint.2018.08.005 · Cited by 266 · see citing works

Review: Role of developmental inflammation and blood–brain barrier dysfunction in neurodevelopmental and neurodegenerative diseases

Stolp, H. B., & Dzięgielewska, K. M. (2008) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2008.01005.x · Cited by 259 · see citing works

Intrathecal minocycline attenuates peripheral inflammation‐induced hyperalgesia by inhibiting p38 MAPK in spinal microglia

Hua, X., Svensson, C. I., Matsui, T., Fitzsimmons, B., Yaksh, T. L., & Webb, M. (2005) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2005.04451.x · Cited by 248 · see citing works

The lipopolysaccharide Parkinson’s disease animal model: mechanistic studies and drug discovery

Dutta, G., Zhang, P., & Liu, B. (2008) · Fundamental & Clinical Pharmacology · doi:10.1111/j.1472-8206.2008.00616.x · Cited by 235 · see citing works

Mechanism of 6‐hydroxydopamine neurotoxicity: the role of NADPH oxidase and microglial activation in 6‐hydroxydopamine‐induced degeneration of dopaminergic neurons

Rodríguez‐Pallares, J., Parga, J. A., Muñoz, A., Rey, P., Guerra, M. J., & Labandeira-García, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04699.x · Cited by 232 · see citing works

Neurotoxic Activation of Microglia Is Promoted by a Nox1-Dependent NADPH Oxidase

Chéret, C., Gervais, A., Lelli, A., Colin, C., Amar, L., Ravassard, P., Mallet, J., Cumano, A., Krause, K.-H., & Mallat, M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3568-08.2008 · Cited by 225 · see citing works

Parkinson's Disease and Systemic Inflammation

Ferrari, C. C., & Tarelli, R. (2011) · Parkinson s Disease · doi:10.4061/2011/436813 · Cited by 218 · see citing works

Ulcerative colitis exacerbates lipopolysaccharide‐induced damage to the nigral dopaminergic system: potential risk factor in Parkinson`s disease

Villarán, R. F., Espinosa‐Oliva, A. M., Soto, M. S., de Pablos, R. M., Argüelles, S., Delgado‐Cortés, M. J., Sobrino, V., van Rooijen, N., Venero, J. L., Herrera, A. J., et al. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06879.x · Cited by 214 · see citing works

Inflammation in Parkinson's Disease

Tüfekçi, K. U., Meuwissen, R. L. J., Genç, Ş., & Genç, K. (2012) · Advances in protein chemistry and structural biology · doi:10.1016/b978-0-12-398314-5.00004-0 · Cited by 199 · see citing works

Lipopolysaccharide Animal Models for Parkinson's Disease

Liu, M., & Bing, G. (2011) · Parkinson s Disease · doi:10.4061/2011/327089 · Cited by 191 · see citing works

Chronic stress as a risk factor for Alzheimer’s disease

Machado, A., Herrera, A. J., de Pablos, R. M., Espinosa‐Oliva, A. M., Soto, M. S., Ayala, A., Venero, J. L., Santiago, M., Villarán, R. F., Delgado‐Cortés, M. J., et al. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2014-0035 · Cited by 177 · see citing works

Modulation of the Purinergic P2X₇Receptor Attenuates Lipopolysaccharide-Mediated Microglial Activation and Neuronal Damage in Inflamed Brain

Choi, H. B., Ryu, J. K., Kim, S. U., & McLarnon, J. G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.5417-06.2007 · Cited by 173 · see citing works

Gene–environment interactions: Key to unraveling the mystery of Parkinson's disease

Gao, H., & Hong, J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.03.005 · Cited by 164 · see citing works

Oxidative Stress and Microglial Cells in Parkinson's Disease

Peterson, L. J., & Flood, P. M. (2012) · Mediators of Inflammation · doi:10.1155/2012/401264 · Cited by 161 · see citing works

Progressive dopamine neuron loss following supra-nigral lipopolysaccharide (LPS) infusion into rats exposed to LPS prenatally

Ling, Z., Zhu, Y., Tong, C. W., Snyder, J. A., Lipton, J. W., & Carvey, P. M. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.01.010 · Cited by 160 · see citing works

Clinical Potential of Minocycline for Neurodegenerative Disorders

BLUM, D., CHTARTO, A., TENENBAUM, L., BROTCHI, J., & LEVIVIER, M. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.07.012 · Cited by 157 · see citing works

Iron deposits in the chronically inflamed central nervous system and contributes to neurodegeneration

Andersen, H. H., Johnsen, K. B., & Moos, T. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1509-8 · Cited by 151 · see citing works

Minocycline alleviates hypoxic–ischemic injury to developing oligodendrocytes in the neonatal rat brain

Cai, Z., Lin, S., Fan, L.-W., Pang, Y., & Rhodes, P. G. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.09.023 · Cited by 141 · see citing works

Minocycline reduces lipopolysaccharide-induced neurological dysfunction and brain injury in the neonatal rat

Fan, L., Pang, Y., Lin, S., Tien, L., Ma, T., Rhodes, P. G., & Cai, Z. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20623 · Cited by 136 · see citing works

Clinical applications of non-antimicrobial tetracyclines in dermatology

Monk, E., Shalita, A. R., & Siegel, D. M. (2010) · Pharmacological Research · doi:10.1016/j.phrs.2010.10.007 · Cited by 132 · see citing works

Blood–brain barrier disruption induces <i>in vivo</i> degeneration of nigral dopaminergic neurons

Rite, I., Machado, A., Cano, J., & Venero, J. L. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04567.x · Cited by 147 · see citing works

Tanshinone I selectively suppresses pro-inflammatory genes expression in activated microglia and prevents nigrostriatal dopaminergic neurodegeneration in a mouse model of Parkinson׳s disease

Wang, S., Jing, H., Yang, H., Liu, Z., Guo, H. W., Chai, L., & Hu, L. (2015) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2015.01.042 · Cited by 126 · see citing works

Intranasal brain delivery of cationic nanoemulsion-encapsulated TNFα siRNA in prevention of experimental neuroinflammation

Yadav, S., Gandham, S. K., Panicucci, R., & Amiji, M. M. (2016) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2015.12.374 · Cited by 125 · see citing works

Interaction of oxidative stress, astrocyte swelling and cerebral ammonia toxicity

Häussinger, D., & Görg, B. (2009) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328333b829 · Cited by 124 · see citing works

Minocycline attenuates lipopolysaccharide-induced white matter injury in the neonatal rat brain

Fan, L.-W., Pang, Y., Lin, S., Rhodes, P. G., & Cai, Z. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.02.016 · Cited by 118 · see citing works

Lipopolysaccharide animal models of Parkinson’s disease: Recent progress and relevance to clinical disease

Deng, I. B., Corrigan, F., Zhai, G., Zhou, X., & Bobrovskaya, L. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100060 · Cited by 120 · see citing works

Blood-brain barrier disruption highly induces aquaporin-4 mRNA and protein in perivascular and parenchymal astrocytes: Protective effect by estradiol treatment in ovariectomized animals

Tomás‐Camardiel, M., Venero, J. L., Herrera, A. J., de Pablos, R. M., Pintor‐Toro, J. A., Machado, A., & Cano, J. (2005) · Journal of Neuroscience Research · doi:10.1002/jnr.20443 · Cited by 116 · see citing works

Neuroprotectant minocycline depresses glutamatergic neurotransmission and Ca2+ signalling in hippocampal neurons

Gonzalez, J., Egea, J., Godino, M. D. C., Fernández-Gómez, F.-J., Sánchez‐Prieto, J., Gandı́a, L., Garcı́a, A. G., Jordán, J., & Hernández-Guijo, J. M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05873.x · Cited by 111 · see citing works

Involvement of Microglia Activation in the Lead Induced Long-Term Potentiation Impairment

Liu, M., Liu, X.-Q., Wang, W., Shen, X., Che, H.-L., Guo, Y., Zhao, M., Chen, J., & Luo, W. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043924 · Cited by 113 · see citing works

Peripheral Inflammation Enhances Microglia Response and Nigral Dopaminergic Cell Death in an in vivo MPTP Model of Parkinson’s Disease

García-Domínguez, I., Veselá, K., García-Revilla, J., Carrillo-Jiménez, A., Roca-Ceballos, M. A., Santiago, M., de Pablos, R. M., & Venero, J. L. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00398 · Cited by 111 · see citing works

Impaired CD200-CD200R-mediated microglia silencing enhances midbrain dopaminergic neurodegeneration: roles of aging, superoxide, NADPH oxidase, and p38 MAPK

Wang, X.-J., Zhang, S., Yan, Z.-Q., Zhao, Y.-X., Zhou, H.-Y., Wang, Y., Lu, G.-Q., & Zhang, J.-D. (2011) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.01.032 · Cited by 108 · see citing works

Neuroprotection by Minocycline Caused by Direct and Specific Scavenging of Peroxynitrite

Schildknecht, S., Pape, R., Müller, N., Robotta, M., Marquardt, A., Bürkle, A., Drescher, M., & Leist, M. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.169565 · Cited by 107 · see citing works

Resident microglia die and infiltrated neutrophils and monocytes become major inflammatory cells in lipopolysaccharide‐injected brain

Ji, K., Yang, M., Jeong, H., Min, K., Kang, S., Jou, I., & Joe, E.-H. (2007) · Glia · doi:10.1002/glia.20571 · Cited by 107 · see citing works

The Endotoxin-Induced Neuroinflammation Model of Parkinson's Disease

Tüfekçi, K. U., Genç, Ş., & Genç, K. (2011) · Parkinson s Disease · doi:10.4061/2011/487450 · Cited by 108 · see citing works

Post‐insult minocycline treatment attenuates hypoxia‐ischemia‐induced neuroinflammation and white matter injury in the neonatal rat: a comparison of two different dose regimens

Carty, M. L., Wixey, J. A., Colditz, P. B., & Buller, K. M. (2008) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2008.02.005 · Cited by 106 · see citing works

Peripheral anti-inflammatory effects explain the ginsenosides paradox between poor brain distribution and anti-depression efficacy

An, K., Hao, H., Zheng, X., Liang, Y. L., Xie, Y., Xie, T., Dai, C., Zhao, Q., Wu, X., Xie, L. Y., et al. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-100 · Cited by 105 · see citing works

Minocycline attenuates hypoxia–ischemia‐induced neurological dysfunction and brain injury in the juvenile rat

Fan, L., Lin, S., Pang, Y., Rhodes, P. G., & Cai, Z. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04918.x · Cited by 101 · see citing works

Modulation of microglial pro-inflammatory and neurotoxic activity for the treatment of Parkinson’s disease

Liu, B. (2006) · The AAPS Journal · doi:10.1208/aapsj080369 · Cited by 100 · see citing works

Nitrosative stress in Parkinson’s disease

Stykel, M. G., & Ryan, S. D. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00370-3 · Cited by 97 · see citing works

Triptolide protects dopaminergic neurons from inflammation-mediated damage induced by lipopolysaccharide intranigral injection

Zhou, H.-F., Liu, X., Niu, D.-B., Li, F., He, Q., & Wang, X.-M. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2004.12.005 · Cited by 99 · see citing works

Minocycline blocks lipopolysaccharide induced hyperalgesia by suppression of microglia but not astrocytes

Yoon, S.-Y., Patel, D. R., & Dougherty, P. M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.024 · Cited by 98 · see citing works

Glial Cells as Therapeutic Approaches in Brain Ischemia-Reperfusion Injury

Hernández, I. H., Villa-González, M., Martín-López, G., Soto, M. S., & Pérez-Álvarez, M. J. (2021) · Cells · doi:10.3390/cells10071639 · Cited by 94 · see citing works

Pathophysiology of the Blood–Brain Barrier: Animal Models and Methods

Hawkins, B. T., & Egleton, R. D. (2007) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/s0070-2153(07)80007-x · Cited by 96 · see citing works

Neuron death and inflammation in a rat model of intracerebral hemorrhage: Effects of delayed minocycline treatment

Wasserman, J. K., & Schlichter, L. C. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.035 · Cited by 96 · see citing works

The synthetic triterpenoid CDDO-methyl ester modulates microglial activities, inhibits TNF production, and provides dopaminergic neuroprotection

Tran, T. A. T., McCoy, M. K., Sporn, M. B., & Tansey, M. G. (2008) · Journal of Neuroinflammation · doi:10.1186/1742-2094-5-14 · Cited by 95 · see citing works

The Therapeutic Role of Minocycline in Parkinson’s Disease

Cankaya, S., Cankaya, B., Kilic, U., Kilic, E., & Yulug, B. (2019) · Drugs in Context · doi:10.7573/dic.212553 · Cited by 93 · see citing works

Minocycline in neurodegenerative and psychiatric diseases: An update

Romero‐Miguel, D., Lamanna‐Rama, N., Casquero‐Veiga, M., Gómez‐Rangel, V., Desco, M., & Soto‐Montenegro, M. L. (2020) · European Journal of Neurology · doi:10.1111/ene.14642 · Cited by 95 · see citing works

The role of Galectin-3 in α-synuclein-induced microglial activation

Boza‐Serrano, A., Reyes, J. F., Rey, N. L., Leffler, H., Bousset, L., Nilsson, U. J., Brundin, P., Venero, J. L., Burguillos, M. Á., & Deierborg, T. (2014) · Acta Neuropathologica Communications · doi:10.1186/s40478-014-0156-0 · Cited by 96 · see citing works

Simvastatin prevents the inflammatory process and the dopaminergic degeneration induced by the intranigral injection of lipopolysaccharide

Hernández-Romero, M. C., Argüelles, S., Villarán, R. F., de Pablos, R. M., Delgado‐Cortés, M. J., Santiago, M., Herrera, A. J., Cano, J., & Machado, A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05148.x · Cited by 91 · see citing works

Peripheral inflammation increases the deleterious effect of CNS inflammation on the nigrostriatal dopaminergic system

Hernández-Romero, M. C., Delgado-Cortés, M. J., Sarmiento, M., de Pablos, R. M., Espinosa-Oliva, A. M., Argüelles, S., Bández, M. J., Villarán, R. F., Mauriño, R., Santiago, M., et al. (2012) · NeuroToxicology · doi:10.1016/j.neuro.2012.01.018 · Cited by 100 · see citing works

Immune-based strategies for mood disorders: facts and challenges

Colpo, G. D., Leboyer, M., Dantzer, R., Trivedi, M. H., & Teixeira, A. L. (2017) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2018.1407242 · Cited by 90 · see citing works

The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment

Varesi, A., Campagnoli, L. I. M., Fahmideh, F., Pierella, E., Romeo, M., Ricevuti, G., Nicoletta, M., Chirumbolo, S., & Pascale, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232012289 · Cited by 88 · see citing works

Peripheral benzodiazepine receptor ligand PK11195 reduces microglial activation and neuronal death in quinolinic acid-injected rat striatum

Ryu, J. K., Choi, H. B., & McLarnon, J. G. (2005) · Neurobiology of Disease · doi:10.1016/j.nbd.2005.04.010 · Cited by 93 · see citing works

Opening of microglial KATP channels inhibits rotenone‐induced neuroinflammation

Zhou, F., Yao, H., Wu, J., Ding, J., Sun, T., & Hu, G. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00144.x · Cited by 84 · see citing works

Tumor Necrosis Factor-α Modulates Cerebral Aneurysm Formation and Rupture

Starke, R. M., Raper, D. M. S., Ding, D., Chalouhi, N., Owens, G. K., Hasan, D. M., Medel, R., & Dumont, A. S. (2013) · Translational Stroke Research · doi:10.1007/s12975-013-0287-9 · Cited by 84 · see citing works

Apoptosis-inducing factor mediates dopaminergic cell death in response to LPS-induced inflammatory stimulus

Burguillos, M. Á., Hajji, N., Englund, E. M., Persson, A., Cenci, M. A., Machado, A., Cano, J., Joseph, B., & Venero, J. L. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.09.005 · Cited by 82 · see citing works

Characterization of peripheral hematopoietic stem cells and monocytes in Parkinson's disease

Funk, N., Wieghofer, P., Grimm, S., Schäfer, R., Bühring, H., Gasser, T., & Biskup, S. (2013) · Movement Disorders · doi:10.1002/mds.25300 · Cited by 81 · see citing works

Mesenchymal stem cells stabilize the blood–brain barrier through regulation of astrocytes

Park, H. J., Shin, J. Y., Kim, H. N., Oh, S. H., Song, S. K., & Lee, P. H. (2015) · Stem Cell Research &amp; Therapy · doi:10.1186/s13287-015-0180-4 · Cited by 79 · see citing works

Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease.

Ryu, J. K., Choi, H. B., & McLarnon, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.05.043 · Cited by 83 · see citing works

Cypermethrin-Induced Nigrostriatal Dopaminergic Neurodegeneration Alters the Mitochondrial Function:A Proteomics Study

Agrawal, S., Singh, A. K., Tripathi, P., Mishra, M., Singh, P. K., & Singh, M. P. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8696-7 · Cited by 76 · see citing works

Minocycline protects against lipopolysaccharide-induced cognitive impairment in mice

Hou, Y., Xie, G., Liu, X., Li, G., Jia, C., Xu, J., & Wang, B. (2015) · Psychopharmacology · doi:10.1007/s00213-015-4169-6 · Cited by 75 · see citing works

Delayed minocycline treatment reduces long-term functional deficits and histological injury in a rodent model of focal ischemia

Hewlett, K. A., & Corbett, D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.071 · Cited by 74 · see citing works

Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?

Buller, K. M., Carty, M. L., Reinebrant, H. E., & Wixey, J. A. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.21890 · Cited by 73 · see citing works

Neuroinflammation and Glial Phenotypic Changes in Alpha-Synucleinopathies

Refolo, V., & Stefanova, N. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00263 · Cited by 71 · see citing works

Neuroinflammation: Microglial Activation During Sepsis

Michels, M., Danielski, L. G., Dal‐Pizzol, F., & Petronilho, F. C. (2014) · Current Neurovascular Research · doi:10.2174/1567202611666140520122744 · Cited by 69 · see citing works

Differential neutrophil infiltration contributes to regional differences in brain inflammation in the substantia nigra pars compacta and cortex

Ji, K., Eu, M. Y., Kang, S., Gwag, B. J., Jou, I., & Joe, E.-H. (2008) · Glia · doi:10.1002/glia.20677 · Cited by 69 · see citing works

Long-term polarization of microglia upon α-synuclein overexpression in nonhuman primates

Barkholt, P., Sánchez-Guajardo, V., Kirik, D., & Romero‐Ramos, M. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.02.004 · Cited by 69 · see citing works

Non-antibiotic properties of tetracyclines and their clinical application in dermatology

Perret, L. J., & Tait, C. P. (2014) · Australasian Journal of Dermatology · doi:10.1111/ajd.12075 · Cited by 68 · see citing works

Microglial Cells as a Link between Cannabinoids and the Immune Hypothesis of Psychiatric Disorders

Lisboa, S. F. D. S., Gomes, F. V., Guimarães, F. S., & Campos, A. C. (2016) · Frontiers in Neurology · doi:10.3389/fneur.2016.00005 · Cited by 69 · see citing works

NADPH oxidase-derived H2O2 mediates the regulatory effects of microglia on astrogliosis in experimental models of Parkinson's disease

Hou, L., Zhou, X., Zhang, C., Wang, K., Liu, X., Che, Y., Sun, F., Li, H., Wang, Q., Zhang, D., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.02.016 · Cited by 66 · see citing works

Minocycline or iNOS inhibition block 3-nitrotyrosine increases and blood–brain barrier leakiness in amyloid beta-peptide-injected rat hippocampus

Ryu, J. K., & McLarnon, J. G. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2005.12.016 · Cited by 66 · see citing works

Systemic lipopolysaccharide (LPS)-induced microglial activation results in different temporal reduction of CD200 and CD200 receptor gene expression in the brain

Masocha, W. (2009) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2009.06.022 · Cited by 65 · see citing works

In vivo expression of aquaporin‐4 by reactive microglia

Tomás‐Camardiel, M., Venero, J. L., de Pablos, R. M., Rite, I., Machado, A., & Cano, J. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02759.x · Cited by 64 · see citing works

Up-regulation of microglial cathepsin C expression and activity in lipopolysaccharide-induced neuroinflammation

Fan, K., Wu, X., Fan, B., Li, N., Lin, Y., Yao, Y., & Ma, J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-96 · Cited by 64 · see citing works

Helicobacter Hypothesis for Idiopathic Parkinsonism: Before and Beyond

Dobbs, R. J., Dobbs, S. M., Weller, C., Charlett, A., Bjarnason, I., Curry, A., Ellis, D. S., Ibrahim, M. A. A., McCrossan, M. V., O’Donohue, J., et al. (2008) · Helicobacter · doi:10.1111/j.1523-5378.2008.00622.x · Cited by 62 · see citing works

Increases in β-amyloid protein in the hippocampus caused by diabetic metabolic disorder are blocked by minocycline through inhibition of NF-κB pathway activation

Cai, Z., Zhao, Y., Yao, S., & Zhao, B. (2011) · Pharmacological Reports · doi:10.1016/s1734-1140(11)70504-7 · Cited by 62 · see citing works

Serum Interleukin (IL)-15 as a Biomarker of Alzheimer's Disease

Bishnoi, R. J., Palmer, R. F., & Royall, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0117282 · Cited by 51 · see citing works

Minocycline prevents the development of depression-like behavior and hippocampal inflammation in a rat model of Alzheimer’s disease

Amani, M., Shokouhi, G., & Salari, A. (2018) · Psychopharmacology · doi:10.1007/s00213-018-5137-8 · Cited by 62 · see citing works

Microglia activation regulates GluR1 phosphorylation in chronic unpredictable stress-induced cognitive dysfunction

Liu, M., Li, J., Dai, P., Zhao, F., Zheng, G., Jing, J., Wang, J., Luo, W., & Chen, J. (2014) · Stress · doi:10.3109/10253890.2014.995085 · Cited by 59 · see citing works

Peripheral Inflammation Increases the Damage in Animal Models of Nigrostriatal Dopaminergic Neurodegeneration: Possible Implication in Parkinson's Disease Incidence

Machado, A., Herrera, A. J., Venero, J. L., Santiago, M., de Pablos, R. M., Villarán, R. F., Espinosa‐Oliva, A. M., Argüelles, S., Sarmiento, M., Delgado‐Cortés, M. J., et al. (2011) · Parkinson s Disease · doi:10.4061/2011/393769 · Cited by 53 · see citing works

Neuroinflammation

Mukhara, D., Oh, U., & Neigh, G. N. (2020) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64123-6.00017-5 · Cited by 58 · see citing works

Minocycline protects dopaminergic neurons in models with lipopolysaccharide-induced Parkinson's disease

Ye, Q.-Y. (2007) · Chinese Journal of Neuromedicine · doi:10.3760/cma.j.issn.1671-8925.2007.12.005

Minocycline protects dopaminergic neurons in lipopolysaccharide.induced model of Parkinson' s disease

An-m, X. (2007)

Minocycline: Neuroprotective Mechanisms in Parkinsons Disease

Thomas, M., & Le, W. (2004) · Current Pharmaceutical Design · doi:10.2174/1381612043453162 · Cited by 114 · see citing works

Blockade of Microglial Activation Is Neuroprotective in the 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine Mouse Model of Parkinson Disease

Wu, D. C., Jackson-Lewis, V., Vila, M., Tieu, K., Teismann, P., Vadseth, C., Choi, D.-K., Ischiropoulos, H., & Przedborski, S. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-05-01763.2002 · Cited by 1,183 · see citing works

Minocycline attenuates TLR-4, NF-kB, TNF-α and COX-2 protein expression after lipopolysaccharide-induced neuroinflammation in the rat medial prefrontal cortex (mPFC)

Qaid, E. Y. A., Abdullah, Z., Zakaria, R., & Long, I. (2025) · Journal of Molecular Histology · doi:10.1007/s10735-025-10419-1 · Cited by 5 · see citing works